Durable efficacy of dolutegravir/rilpivirine switch in subjects with HIV RNA <50 copies/ml and history of K103N mutation.
| Published in: | AIDS (02699370) Vol. 40; no. 7; pp. 885 - 894 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Published: |
Lippincott Williams & Wilkins
Jul2026
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=194128139&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 194128139 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 02699370 6FD jtl: AIDS (02699370) issn: 02699370 maglogo: N pubinfo: dt: Jul2026 vid: 40 iid: 7 pid: 433 pub: Lippincott Williams & Wilkins place: Baltimore, Maryland artinfo: ui: 194128139 10.1097/QAD.0000000000004451 194128139 ppf: 885 ppct: 9 formats: tig: atl: Durable efficacy of dolutegravir/rilpivirine switch in subjects with HIV RNA <50 copies/ml and history of K103N mutation. aug: au: Moyle, Graeme Assoumou, Lambert De Castro, Nathalie Post, Frank A. Curran, Adrian Rusconi, Stefano De Wit, Stephane Stephan, Christoph Raffi, François Johnson, Margaret Masiá, Mar Vera, Jaime Jones, Bryn Fletcher, Carl Morris, Kellie Pozniak, Anton affil: Chelsea and Westminster Hospital, London, UK sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|